98
Views
12
CrossRef citations to date
0
Altmetric
Original Research

LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 287-296 | Published online: 12 Jan 2021

References

  • Carcas LP. Gastric cancer review. J Carcinog. 2014;13(1):14. doi:10.4103/1477-3163.14650625589897
  • YiRen H, YingCong Y, Sunwu Y, et al. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. Mol Cancer. 2017;16(1):174. doi:10.1186/s12943-017-0743-329162158
  • Goere D, Gras-Chaput N, Auperin A, et al. Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab. BMC Cancer. 2014;14(1):148. doi:10.1186/1471-2407-14-14824589307
  • Kalmar A, Nagy ZB, Galamb O, et al. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition. BMC Cancer. 2019;19(1):1059. doi:10.1186/s12885-019-6180-531694571
  • Yang H, Jiang Z, Wang S, et al. Long non-coding small nucleolar RNA host genes in digestive cancers. Cancer Med. 2019;8(18):7693–7704. doi:10.1002/cam4.262231691514
  • Barth DA, Slaby O, Klec C, et al. Current concepts of non-coding RNAs in the pathogenesis of non-clear cell renal cell carcinoma. Cancers (Basel). 2019;11(10):1580. doi:10.3390/cancers11101580
  • Bourguignon LYW. Matrix hyaluronan-CD44 interaction activates microRNA and LncRNA signaling associated with chemoresistance, invasion, and tumor progression. Front Oncol. 2019;9:492. doi:10.3389/fonc.2019.0049231293964
  • Zebisch A, Hatzl S, Pichler M, et al. Therapeutic resistance in acute myeloid leukemia: the role of non-coding RNAs. Int J Mol Sci. 2016;17(12):12. doi:10.3390/ijms17122080
  • Li Y, Ye Y, Feng B, Qi Y. Long noncoding RNA lncARSR promotes doxorubicin resistance in hepatocellular carcinoma via modulating PTEN-PI3K/Akt pathway. J Cell Biochem. 2017;118(12):4498–4507. doi:10.1002/jcb.2610728464252
  • Wu X, Zheng Y, Han B, Dong X. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361. Biomed Pharmacother. 2018;99:832–838. doi:10.1016/j.biopha.2018.01.13029710482
  • Flockhart RJ, Webster DE, Qu K, et al. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012;22(6):1006–1014. doi:10.1101/gr.140061.11222581800
  • Li L, Zhang L, Zhang Y, Zhou F. Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer. Biomed Pharmacother. 2015;72:109–112. doi:10.1016/j.biopha.2015.04.00726054683
  • Wagner AD, Syn NL, Moehler M, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8:CD004064. doi:10.1002/14651858.CD004064.pub428850174
  • Wang Y, Gu J, Lin X, et al. lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway. Oncol Lett. 2018;15(4):5865–5870. doi:10.3892/ol.2018.801729552216
  • Wang Y, Lin X, Fu X, et al. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway. Oncol Rep. 2018;40(2):859–866. doi:10.3892/or.2018.650229917164
  • Chen Z, Pan T, Jiang D, et al. The lncRNA-GAS5/miR-221-3p/DKK2 axis modulates abcb1-mediated adriamycin resistance of breast cancer via the Wnt/beta-catenin signaling pathway. Mol Ther Nucleic Acids. 2020;19:1434–1448. doi:10.1016/j.omtn.2020.01.03032160712
  • Wei L, Sun J, Zhang N, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62. doi:10.1186/s12943-020-01185-732192494
  • Mondal P, Natesh J, Kamal MA, Meeran SM. Non-coding RNAs in lung cancer chemoresistance. Curr Drug Metab. 2020;20(13):1023–1032. doi:10.2174/1389200221666200106105201
  • Shi S, Wang L, Yu B, et al. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget. 2015;6(13):11652–11663. doi:10.18632/oncotarget.345725871474
  • Fang X, Pan H, Leng R, Ye D. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015;356(2):357–366. doi:10.1016/j.canlet.2014.11.00525444905
  • Chen X, Wang Z, Tong F, et al. lncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer. Mol Ther Nucleic Acids. 2020;19:643–653. doi:10.1016/j.omtn.2019.10.04731951852
  • Wang D, Wang D, Wang N, et al. Long non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathway. Cell Physiol Biochem. 2016;40(3–4):644–656.27898420
  • He A, Liu Y, Chen Z, et al. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer. J Exp Clin Cancer Res. 2016;35(1):125. doi:10.1186/s13046-016-0397-927514530
  • Shi Y, Liu Y, Wang J, et al. Downregulated long noncoding RNA BANCR promotes the proliferation of colorectal cancer cells via downregulation of p21 expression. PLoS One. 2015;10(4):e0122679. doi:10.1371/journal.pone.012267925928067
  • Li J, Wang J, Zhou W, et al. Downregulation of BRAF-activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells. Oncol Lett. 2017;14(4):4751–4757. doi:10.3892/ol.2017.677029085476
  • Zhang ZX, Liu ZQ, Jiang B, et al. BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-kappaB1. Biochem Biophys Res Commun. 2015;465(2):225–231. doi:10.1016/j.bbrc.2015.07.15826248136
  • Ma S, Yang D, Liu Y, et al. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer. Aging (Albany NY). 2018;10(8):2062–2078. doi:10.18632/aging.10153030144787
  • McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochem Biophys Acta. 2007;1773(8):1263–1284.17126425
  • Tung S-L, Huang W-C, Hsu F-C, et al. miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway. Oncogenesis. 2017;6(5):e326. doi:10.1038/oncsis.2017.2528459431
  • Liu QG, Li YJ, Yao L. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis. Pancreatology. 2018;18(6):678–688. doi:10.1016/j.pan.2018.07.00330055941
  • Li L, Cui Y, Ye L, et al. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer. Int J Oncol. 2018;53(3):1171–1182. doi:10.3892/ijo.2018.445529956751
  • Kapusta A, Feschotte C. Volatile evolution of long noncoding RNA repertoires: mechanisms and biological implications. Trends Genet. 2014;30(10):439–452. doi:10.1016/j.tig.2014.08.00425218058
  • Wu X, Xia T, Cao M, et al. LncRNA BANCR promotes pancreatic cancer tumorigenesis via modulating MiR-195-5p/Wnt/beta-catenin signaling pathway. Technol Cancer Res Treat. 2019;18:1533033819887962. doi:10.1177/153303381988796231769353
  • Jiang X, Liu Z, Qi X. LncRNA BANCR induced vascular smooth muscle cell proliferation by downregulating miR-34c methylation in atherosclerosis. J Thromb Thrombolysis. 2020. doi:10.1007/s11239-020-02314-1